These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 113864)

  • 21. [The achievements of the fundamental sciences and new approaches in the chemotherapy of tuberculosis].
    Egorov AM
    Probl Tuberk; 2000; (5):11-5. PubMed ID: 11077844
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the role of the macroorganism in the appearance of bacillary resistance].
    Nitti V
    Ftiziologia; 1971; 20(3):245-8. PubMed ID: 5005958
    [No Abstract]   [Full Text] [Related]  

  • 23. [Mycobacterium tuberculosis after five 5-year periods of specific therapy. Biological aspects].
    Daddi G
    Ann Ist Carlo Forlanini; 1969; 29(4):283-5. PubMed ID: 5004327
    [No Abstract]   [Full Text] [Related]  

  • 24. [Resistance to antituberculosis drug in France; data provided by the Azay-Mycobacteria network and the National Reference Center on Mycobacteria].
    Robert J; Veziris N;
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S68-70. PubMed ID: 18598875
    [No Abstract]   [Full Text] [Related]  

  • 25. [Resistance to antitubercular drugs in strains of Mycobacterium tuberculosis isolated in Spain].
    Ausina Ruiz V; Lonca Giménez J
    Rev Clin Esp; 1999 Mar; 199(3):121-5. PubMed ID: 10230288
    [No Abstract]   [Full Text] [Related]  

  • 26. Azole antifungals as novel chemotherapeutic agents against murine tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2006 Aug; 261(2):181-6. PubMed ID: 16907718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sensitivity of Mycobacterium tuberculosis in our environment].
    Unzaga MJ; Sota M; Melero P; Berdonces P; Ezpeleta C; Cisterna R
    Enferm Infecc Microbiol Clin; 1996; 14(6):399-400. PubMed ID: 8756225
    [No Abstract]   [Full Text] [Related]  

  • 28. Dosing regimens in the treatment of tuberculosis.
    Blom-Bülow B
    Scand J Infect Dis Suppl; 1990; 74():258-61. PubMed ID: 2129066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Virulence and dynamics of the degree of drug resistance of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1965; 43(3):60-6. PubMed ID: 4954936
    [No Abstract]   [Full Text] [Related]  

  • 30. [New antitubercular drugs].
    Krasucka-Kluźniak A
    Pneumonol Pol; 1990; 58(4-5):163-6. PubMed ID: 2168041
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antitubercular agents--recent developments in assessment and use].
    Ludes H
    Internist (Berl); 1989 Jan; 30(1):38-45. PubMed ID: 2493430
    [No Abstract]   [Full Text] [Related]  

  • 32. [Morphological aspects of the infection and re-infection with M.t. (Mycobacterium tuberculosis) resistant to chemo-antibiotics].
    Stroniello G
    Arch Monaldi; 1972; 27(3):284-9. PubMed ID: 4219269
    [No Abstract]   [Full Text] [Related]  

  • 33. Virulence attenuation and other biological modifications in multiple drug resistant tubercle mycobacteria.
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P; Serafini NA; Termine A; Zubiani M
    Boll Ist Sieroter Milan; 1971; 50(4):353-61. PubMed ID: 5005885
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy in tuberculosis].
    Somoskövi A; Lantos A
    Orv Hetil; 2004 Apr; 145(16):871-3. PubMed ID: 15156693
    [No Abstract]   [Full Text] [Related]  

  • 35. Introduction to a formal theory of the dosage regimen calculation in intermittent chemotherapy of tuberculosis.
    Bercea O; Bonciocat N
    Arzneimittelforschung; 1970 Feb; 20(2):241-5. PubMed ID: 4986038
    [No Abstract]   [Full Text] [Related]  

  • 36. Pancreatic mass caused by Mycobacterium tuberculosis with reduced drug sensitivity.
    Small G; Wilks D
    J Infect; 2001 Apr; 42(3):201-2. PubMed ID: 11545552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 38. [Behavior of drug-resistant mutants of the H37 Rv tubercular strain in experimental tuberculosis of the guinea pig].
    Aliperta A; Ninni A
    Arch Monaldi; 1972; 27(3):72-9. PubMed ID: 4219271
    [No Abstract]   [Full Text] [Related]  

  • 39. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Influence of background factors, factors regarding the method of treatment and the course of the disease on the emergence of drug resistance].
    Yamamoto M; Nakamura H; Inagaki H
    Kekkaku; 1970 Oct; 45(10):349-57. PubMed ID: 4991618
    [No Abstract]   [Full Text] [Related]  

  • 40. [Response to the short-course chemotherapy in patients presenting initial resistance].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):41-3. PubMed ID: 2416375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.